Literature DB >> 9327988

Dopamine-mediated gene regulation in the striatum.

C R Gerfen1, K A Keefe, H Steiner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9327988     DOI: 10.1016/s1054-3589(08)60837-6

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


× No keyword cloud information.
  5 in total

1.  Involvement of dopaminergic processes in the striatum during the effects of corticoliberin on the behavior of active and passive rats.

Authors:  V G Shalyapina; V V Rakitskaya; G G Rodionov
Journal:  Neurosci Behav Physiol       Date:  2003-07

2.  Differential excitability and modulation of striatal medium spiny neuron dendrites.

Authors:  Michelle Day; David Wokosin; Joshua L Plotkin; Xinyoung Tian; D James Surmeier
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

3.  Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

Authors:  Jianhong Li; Yin Guo; Frederick A Schroeder; Rachael M Youngs; Thomas W Schmidt; Craig Ferris; Christine Konradi; Schahram Akbarian
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

4.  Future of cell and gene therapies for Parkinson's disease.

Authors:  Ole Isacson; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

5.  Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease.

Authors:  Sora Ahn; Taek-Jin Song; Seong-Uk Park; Songhee Jeon; Jongpil Kim; Joo-Young Oh; Jaehwan Jang; Sanhwa Hong; Min-A Song; Hye-Seoung Shin; Young-Rim Jung; Hi-Joon Park
Journal:  BMC Complement Altern Med       Date:  2017-04-19       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.